Strata Critical Medical (SRTA) Accumulated Depreciation & Amortization (2023 - 2026)

Strata Critical Medical (SRTA) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $3.1 million in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization rose 80.32% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 80.32% YoY) and the FY2025 annual result came in at $8.2 million, up 37.29% from the prior year.
• Accumulated Depreciation & Amortization fell to $3.1 million in Q1 2026 per SRTA's latest filing, from $8.2 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $8.2 million in Q4 2025 and bottomed at $1.6 million in Q1 2024.
• The 4-year median for Accumulated Depreciation & Amortization is $3.2 million (2023), against an average of $3.6 million.
• The widest annual swing landed in 2024, when Accumulated Depreciation & Amortization soared 140.48%; it then gained 6.46% in 2025.
• Tracing SRTA's Accumulated Depreciation & Amortization over 4 years: stood at $3.2 million in 2023, then surged by 88.97% to $6.0 million in 2024, then surged by 37.29% to $8.2 million in 2025, then slumped by 62.61% to $3.1 million in 2026.
• Per Business Quant, the three latest SRTA Accumulated Depreciation & Amortization figures stand at $3.1 million (Q1 2026), $8.2 million (Q4 2025), and $5.2 million (Q3 2025).

Peer Comparison